Linden Thomas Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,094
Closed -$478K 400
2023
Q2
$478K Sell
5,094
-50
-1% -$3.9K 0.11% 308
2023
Q1
$349K Buy
5,144
+395
+8% +$25.4K 0.09% 312
2022
Q4
$235K Buy
+4,749
New +$194K 0.07% 323

Other funds holding EXAS

Linden Thomas Advisory Services's EXAS Position: Q3 2023 in Review

Linden Thomas Advisory Services sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 5,094 shares — an estimated $478K sold.

Linden Thomas Advisory Services first reported a position in EXAS in Q4 2022 and held it in 3 quarters. The position peaked at $478K in Q2 2023. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Linden Thomas Advisory Services reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Linden Thomas Advisory Services sold 5,094 Exact Sciences shares in Q3 2023, an estimated $478K.
  • Linden Thomas Advisory Services first reported a position in Exact Sciences in Q4 2022 and held it in 3 quarters.
  • Linden Thomas Advisory Services's Exact Sciences position peaked at $478K in Q2 2023.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2023, filed 20 Oct 2023.